Perspectives of Medical Specialists on Sharing Decisions in Cancer Care: A Qualitative Study Concerning Chemotherapy Decisions With Patients With Recurrent Glioblastoma

被引:17
作者
De Snoo-Trimp, Janine C. [1 ]
Brom, Linda [2 ]
Pasman, H. Roeline W. [2 ]
Onwuteaka-Philipsen, Bregje D. [2 ]
Widdershoven, Guy A. M. [1 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Expertise Ctr Palliat Care, Dept Med Humanities, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Publ & Occupat Hlth, Amsterdam, Netherlands
关键词
Shared decision making; Medical specialists; Glioblastoma; Qualitative research; End-of-life care; Medical ethics; END-OF-LIFE; HIGH-GRADE GLIOMA; PALLIATIVE CHEMOTHERAPY; NURSE-CONSULTANT; PARTICIPATION; TEMOZOLOMIDE; AGGRESSIVENESS; COMMUNICATION; CLINICIAN;
D O I
10.1634/theoncologist.2015-0095
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. In cancer care, difficult decisions concerning advanced treatment need to be made, weighing possible life prolongation against harmful side effects. Treatment is frequently started, showing the need to explore how decisions are made. Little is known about the perspectives of physicians on sharing decision making with patients. This qualitative study aimed to describe the perspectives of medical specialists on the decision-making process with patients with glioblastoma concerning starting new treatment. Methods. Qualitative interviews were held with medical specialists. One focus group was organized with medical professionals. Their opinions about elements of shared decision making and the applicability in the context of patients with glioblastoma were assessed. The topic list for the focus group was based on the analysis of the interviews. Qualitative analysis of the transcripts was performed by three researchers independently. Results. Medical specialists considered shared decision making to be important; however, they did not adhere to its elements. Stopping treatment was not considered equal to continuing treatment. Exploration of the patients' wishes was done implicitly, and shared responsibility for the decision was not highly recognized. The main barriers to shared decision making were preferences of both patients and specialists for starting or continuing treatment and assumptions of physicians about knowing what patients want. Conclusion. Medical specialists recognized the importance of patient involvement but experienced difficulty in sharing decision making in practice. Elements of shared decision making are partly followed but do not guide decision making. To improve cancer care, education of medical specialists and adjustment to the elements are needed to involve patients.
引用
收藏
页码:1182 / 1188
页数:7
相关论文
共 49 条
  • [21] A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma
    Fabrini, Maria Grazia
    Silvano, Giovanni
    Lolli, Ivan
    Perrone, Franco
    Marsella, Annarita
    Scotti, Valerio
    Cionini, Luca
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2009, 92 (01) : 79 - 86
  • [22] Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
    Friedman, Henry S.
    Prados, Michael D.
    Wen, Patrick Y.
    Mikkelsen, Tom
    Schiff, David
    Abrey, Lauren E.
    Yung, W. K. Alfred
    Paleologos, Nina
    Nicholas, Martin K.
    Jensen, Randy
    Vredenburgh, James
    Huang, Jane
    Zheng, Maoxia
    Cloughesy, Timothy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : 4733 - 4740
  • [23] A systematic review of physicians' survival predictions in terminally ill cancer patients
    Glare, P
    Virik, K
    Jones, M
    Hudson, M
    Eychmuller, S
    Simes, J
    Christakis, N
    [J]. BRITISH MEDICAL JOURNAL, 2003, 327 (7408): : 195 - 198
  • [24] Consultant nurse-consultant physician: a new partnership for patient-centred care?
    Graham, Iain W.
    [J]. JOURNAL OF CLINICAL NURSING, 2007, 16 (10) : 1809 - 1817
  • [25] How should patients behave to facilitate shared decision making - the doctors' view
    Hamann, Johannes
    Mendel, Rosmarie
    Buehner, Markus
    Kissling, Werner
    Cohen, Rudolf
    Knipfer, Eva
    Eckstein, Hans-Henning
    [J]. HEALTH EXPECTATIONS, 2012, 15 (04) : 360 - 366
  • [26] Factors That Affect the Duration of the Interval Between the Completion of Palliative Chemotherapy and Death
    Hashimoto, Kenji
    Yonemori, Kan
    Katsumata, Noriyuki
    Hotchi, Marika
    Kouno, Tsutomu
    Shimizu, Chikako
    Tamura, Kenji
    Ando, Masashi
    Takeuchi, Masahiro
    Fujiwara, Yasuhiro
    [J]. ONCOLOGIST, 2009, 14 (07) : 752 - 759
  • [27] Salvage therapy in patients with glioblastoma -: Is there any benefit?
    Hau, P
    Baumgart, U
    Pfeifer, K
    Bock, A
    Jauch, T
    Dietrich, J
    Fabel, K
    Grauer, O
    Wismeth, C
    Klinkhammer-Schalke, M
    Allgäuer, M
    Schuierer, G
    Koch, H
    Schlaier, J
    Brawanski, A
    Bogdahn, U
    Steinbrecher, A
    [J]. CANCER, 2003, 98 (12) : 2678 - 2686
  • [28] Aggressiveness of cancer-care near the end-of-life in Korea
    Keam, Bhumsuk
    Oh, Do-Youn
    Lee, Se-Hoon
    Kim, Dong-Wan
    Kim, Mi Ra
    Im, Seock-Ah
    Kim, Tae-You
    Bang, Yung-Jue
    Heo, Dae Seog
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (05) : 381 - 386
  • [29] Discontinuing Bevacizumab in Patients with Glioblastoma: An Ethical Analysis
    Kesselheim, Jennifer C.
    Norden, Andrew D.
    Wen, Patrick Y.
    Joffe, Steven
    [J]. ONCOLOGIST, 2011, 16 (10) : 1435 - 1439
  • [30] Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients
    Klein, M
    Taphoorn, MJB
    Heimans, JJ
    van der Ploeg, HM
    Vandertop, WP
    Smit, EF
    Leenstra, S
    Tulleken, CAF
    Boogerd, W
    Belderbos, JSA
    Cleijne, W
    Aaronson, NK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (20) : 4037 - 4047